These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38402802)

  • 21. Policy actor views on structural vulnerability in harm reduction and policymaking for illegal drugs: A qualitative study.
    Gehring ND; Speed KA; Wild TC; Pauly B; Salvalaggio G; Hyshka E
    Int J Drug Policy; 2022 Oct; 108():103805. PubMed ID: 35907373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. "Am I gonna get in trouble for acknowledging my will to be safe?": Identifying the experiences of young sexual minority men and substance use in the context of an opioid overdose crisis.
    Goodyear T; Mniszak C; Jenkins E; Fast D; Knight R
    Harm Reduct J; 2020 Mar; 17(1):23. PubMed ID: 32228646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A qualitative study on perceptions and experiences of overdose among people who smoke drugs in Vancouver, British Columbia.
    Ivsins A; Bonn M; McNeil R; Boyd J; Kerr T
    Drug Alcohol Depend; 2024 May; 258():111275. PubMed ID: 38581922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and characteristics of the Provincial Overdose Cohort in British Columbia, Canada.
    MacDougall L; Smolina K; Otterstatter M; Zhao B; Chong M; Godfrey D; Mussavi-Rizi A; Sutherland J; Kuo M; Kendall P
    PLoS One; 2019; 14(1):e0210129. PubMed ID: 30629607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk mitigation guidance and safer supply prescribing among young people who use drugs in the context of COVID-19 and overdose emergencies.
    Giang K; Charlesworth R; Thulien M; Mulholland A; Barker B; Brar R; Pauly B; Fast D
    Int J Drug Policy; 2023 May; 115():104023. PubMed ID: 37059025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "It's an emotional roller coaster… But sometimes it's fucking awesome": Meaning and motivation of work for peers in overdose response environments in British Columbia.
    Pauly BB; Mamdani Z; Mesley L; McKenzie S; Cameron F; Edwards D; Howell A; Knott M; Scott T; Seguin R; Greer AM; Buxton JA
    Int J Drug Policy; 2021 Feb; 88():103015. PubMed ID: 33176249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between toxic drug events and encephalopathy in British Columbia, Canada: a cross-sectional analysis.
    Xavier CG; Kuo M; Desai R; Palis H; Regan G; Zhao B; Moe J; Scheuermeyer FX; Gan WQ; Sabeti S; Meilleur L; Buxton JA; Slaunwhite AK
    Subst Abuse Treat Prev Policy; 2023 Jul; 18(1):42. PubMed ID: 37420239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decriminalization thresholds for drug possession: A multi-criteria policy analysis framework.
    McAdam E; Small W; Mullins G; Graham B; Greer A; Winder N; DeBeck K
    Int J Drug Policy; 2023 Sep; 119():104126. PubMed ID: 37454608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identifying behaviours for survival and wellness among people who use methamphetamine with opioids in British Columbia: a qualitative study.
    Corser J; Palis H; Fleury M; Lamb J; Lock K; McDougall J; Mehta A; Newman C; Spence H; Buxton JA
    Harm Reduct J; 2022 May; 19(1):46. PubMed ID: 35590375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. (Re)situating expertise in community-based overdose response: Insights from an ethnographic study of overdose prevention sites (OPS) in Vancouver, Canada.
    Olding M; Boyd J; Kerr T; Fowler A; McNeil R
    Int J Drug Policy; 2023 Jan; 111():103929. PubMed ID: 36529032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. British Columbia's Safer Opioid Supply Policy and Opioid Outcomes.
    Nguyen HV; Mital S; Bugden S; McGinty EE
    JAMA Intern Med; 2024 Mar; 184(3):256-264. PubMed ID: 38227344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The implementation of overdose prevention sites as a novel and nimble response during an illegal drug overdose public health emergency.
    Wallace B; Pagan F; Pauly BB
    Int J Drug Policy; 2019 Apr; 66():64-72. PubMed ID: 30708237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spatial-temporal trends in the risk of illicit drug toxicity death in British Columbia.
    Hu K; Klinkenberg B; Gan WQ; Slaunwhite AK
    BMC Public Health; 2022 Nov; 22(1):2121. PubMed ID: 36401244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "It gets you high as a kite but not unsick": Characterizations of and responses to a changing local drug supply by people who use drugs in Rhode Island.
    Collins AB; Macon EC; Levin S; Wunsch C; Wightman RS
    Int J Drug Policy; 2024 May; 127():104391. PubMed ID: 38490014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The "goldfish bowl": a qualitative study of the effects of heightened surveillance on people who use drugs in a rural and coastal Canadian setting.
    Bardwell G; Mansoor M; Van Zwietering A; Cleveland E; Snell D; Kerr T
    Harm Reduct J; 2022 Dec; 19(1):136. PubMed ID: 36476225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. "We just don't have the space for it": Geographies of survival and spatial triage in overdose prevention sites.
    Olding M; Boyd J; Kerr T; McNeil R
    Health Place; 2023 Sep; 83():103067. PubMed ID: 37352615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implementation of Safe Supply Alternatives During Intersecting COVID-19 and Overdose Health Emergencies in British Columbia, Canada, 2021.
    McNeil R; Fleming T; Mayer S; Barker A; Mansoor M; Betsos A; Austin T; Parusel S; Ivsins A; Boyd J
    Am J Public Health; 2022 Apr; 112(S2):S151-S158. PubMed ID: 35262376
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of risk mitigation measures for people with substance use disorders to address the dual public health crises of COVID-19 and overdose in British Columbia: a mixed-method study protocol.
    Nosyk B; Slaunwhite A; Urbanoski K; Hongdilokkul N; Palis H; Lock K; Min JE; Zhao B; Card KG; Barker B; Meilleur L; Burmeister C; Thomson E; Beck-McGreevy P; Pauly B
    BMJ Open; 2021 Jun; 11(6):e048353. PubMed ID: 34108170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors associated with take-home naloxone kit usage in British Columbia: an analysis of administrative data.
    Lei V; Ferguson M; Geiger R; Williams S; Liu L; Buxton JA
    Subst Abuse Treat Prev Policy; 2022 Mar; 17(1):25. PubMed ID: 35361228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Housing and overdose: an opportunity for the scale-up of overdose prevention interventions?
    Bardwell G; Collins AB; McNeil R; Boyd J
    Harm Reduct J; 2017 Dec; 14(1):77. PubMed ID: 29212507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.